Guardant Health (NASDAQ: GH)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.210 | -0.910 | 0.3000 | ||||
REV | 95.700M | 96.099M | 399.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Guardant Health (NASDAQ: GH) through any online brokerage.
Other companies in Guardant Health’s space includes: CVS Health (NYSE:CVS), Signify Health (NYSE:SGFY), Chemed (NYSE:CHE), LHC Gr (NASDAQ:LHCG) and Agiliti (NYSE:AGTI).
The latest price target for Guardant Health (NASDAQ: GH) was reported by Piper Sandler on Friday, June 3, 2022. The analyst firm set a price target for 65.00 expecting GH to rise to within 12 months (a possible 44.12% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Guardant Health (NASDAQ: GH) is $45.1 last updated Today at July 5, 2022, 4:53 PM UTC.
There are no upcoming dividends for Guardant Health.
Guardant Health’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Guardant Health.
Guardant Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.